Search
for
Sort by
Research 721–750 of 920
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA)
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Treatment of pediatric alopecia areata: A systematic review
- Poliosis circumscripta: Overview and underlying causes
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Female pattern alopecia: current perspectives
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Alopecia: A review of laser and light therapies
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Eyebrow Loss
- Alopecia and Associated Toxic Agents: A Systematic Review
- Treating Alopecia Areata: Current Practices Versus New Directions
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Treatments for alopecia areata: A systematic review and network meta‐analysis
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- JAK inhibition decreases the autoimmune burden in Down syndrome
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Treatment of Alopecia Areata With Topical Sensitizers
- Skin transcriptome reveals the periodic changes in genes underlying cashmere (ground hair) follicle transition in cashmere goats